InsiderTrades

Form 4 for HCWB HCW Biologics Inc.

Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-22 · accession 0001209191-21-048063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-23 2021-07-22 HCWB Wong Hing C CEO, Dir P - Purchase $8.00 +627.5K 15.26M +4% +$5.02M
DM 2021-07-23 2021-07-22 HCWB Wong Hing C CEO, Dir C - Cnv Deriv $0.00 +10.34M 14.63M +241% $0
DM 2021-07-23 2021-07-22 HCWB Wong Hing C CEO, Dir C - Cnv Deriv $0.00 -10.34M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-22 P A 627,500 $8.00 15,255,618 D — — (F3) Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang. (F4) Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share.
2 Common Common Stock 2021-07-22 C A 6,316,691 $0.00 10,602,405 D — — (F1) Represents shares received upon the conversion of shares of Series A Redeemable Convertible Preferred Stock. Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
3 Common Common Stock 2021-07-22 C A 2,954,285 $0.00 13,556,690 D — — (F2) Represents shares received upon the conversion of shares of Series B Redeemable Convertible Preferred Stock. Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
4 Common Common Stock 2021-07-22 C A 1,071,428 $0.00 14,628,118 D — — (F3) Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang.
5 Derivative Series C Redeemable Preferred Stock 2021-07-22 C D 1,071,428 $0.00 0 D — · — to — 1,071,428 Common Stock (F3) Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang. (F7) Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
6 Derivative Series B Redeemable Preferred Stock 2021-07-22 C D 2,954,285 $0.00 0 D — · — to — 2,954,285 Common Stock (F2) Represents shares received upon the conversion of shares of Series B Redeemable Convertible Preferred Stock. Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang. (F6) Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
7 Derivative Series A Redeemable Preferred Stock 2021-07-22 C D 6,316,691 $0.00 0 D — · — to — 6,316,691 Common Stock (F1) Represents shares received upon the conversion of shares of Series A Redeemable Convertible Preferred Stock. Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang. (F5) Each share of the Series A Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.